Deutsche Bank AG Purchases Shares of 131,539 Mettler-Toledo International, Inc. $MTD

Deutsche Bank AG purchased a new position in shares of Mettler-Toledo International, Inc. (NYSE:MTD) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 131,539 shares of the medical instruments supplier’s stock, valued at approximately $168,042,000.

Several other hedge funds have also made changes to their positions in the business. Aware Super Pty Ltd as trustee of Aware Super acquired a new position in Mettler-Toledo International in the first quarter valued at $26,372,000. M&T Bank Corp boosted its stake in Mettler-Toledo International by 2,813.6% in the 4th quarter. M&T Bank Corp now owns 124,205 shares of the medical instruments supplier’s stock worth $173,165,000 after buying an additional 119,942 shares during the last quarter. Strs Ohio boosted its stake in Mettler-Toledo International by 2,594.8% in the 4th quarter. Strs Ohio now owns 13,393 shares of the medical instruments supplier’s stock worth $18,672,000 after buying an additional 12,896 shares during the last quarter. Crossmark Global Holdings Inc. grew its holdings in Mettler-Toledo International by 34.3% in the 4th quarter. Crossmark Global Holdings Inc. now owns 4,150 shares of the medical instruments supplier’s stock valued at $5,786,000 after buying an additional 1,060 shares during the period. Finally, Fifth Third Bancorp grew its holdings in Mettler-Toledo International by 377.3% in the 1st quarter. Fifth Third Bancorp now owns 4,181 shares of the medical instruments supplier’s stock valued at $5,272,000 after buying an additional 3,305 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Insider Buying and Selling

In other Mettler-Toledo International news, Director Thomas P. Salice sold 417 shares of the business’s stock in a transaction on Wednesday, August 5th. The shares were sold at an average price of $1,440.41, for a total value of $600,650.97. Following the transaction, the director owned 292 shares in the company, valued at $420,599.72. The trade was a 58.82% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Shawn Vadala sold 2,240 shares of the company’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $1,432.00, for a total transaction of $3,207,680.00. Following the completion of the transaction, the chief financial officer directly owned 5,579 shares of the company’s stock, valued at approximately $7,989,128. The trade was a 28.65% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 3,312 shares of company stock valued at $4,750,362 in the last quarter. Company insiders own 0.71% of the company’s stock.

Mettler-Toledo International Stock Up 1.8%

Shares of NYSE:MTD opened at $1,424.86 on Thursday. The company has a market capitalization of $28.55 billion, a price-to-earnings ratio of 32.07, a price-to-earnings-growth ratio of 2.88 and a beta of 1.23. The company has a 50 day moving average of $1,309.30 and a two-hundred day moving average of $1,273.33. Mettler-Toledo International, Inc. has a 52-week low of $1,023.05 and a 52-week high of $1,525.17. The company has a quick ratio of 0.78, a current ratio of 1.12 and a debt-to-equity ratio of 159.45.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 EPS for the quarter, topping analysts’ consensus estimates of $10.78 by $0.68. The business had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $1.03 billion. Mettler-Toledo International had a net margin of 21.91% and a negative return on equity of 1,212.14%. The business’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period in the previous year, the company posted $10.09 earnings per share. As a group, analysts forecast that Mettler-Toledo International, Inc. will post 47.35 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages have recently weighed in on MTD. Wells Fargo & Company increased their price objective on shares of Mettler-Toledo International from $1,225.00 to $1,450.00 and gave the stock an “equal weight” rating in a report on Monday, August 3rd. Robert W. Baird lowered their target price on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating for the company in a report on Monday, May 11th. Weiss Ratings raised shares of Mettler-Toledo International from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, August 4th. Barclays increased their price target on shares of Mettler-Toledo International from $1,300.00 to $1,575.00 and gave the stock an “overweight” rating in a research note on Monday, August 3rd. Finally, Wall Street Zen lowered shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a report on Saturday, May 16th. Six analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $1,461.27.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.